Single-dose Rituximab Therapy for Refractory Idiopathic Membranous Nephropathy: A Single-center Experience

To date, a recognized treatment for refractory membranous nephropathy (MN) has not been established. Recently, several reports have indicated the efficacy of rituximab as a novel treatment option. However, only a few published accounts exist of rituximab therapy for idiopathic MN (IMN) in the Asian...

Descripción completa

Detalles Bibliográficos
Autores principales: Katsuno, Takayuki, Ozaki, Takenori, Kim, Hangsoo, Kato, Noritoshi, Suzuki, Yasuhiro, Akiyama, Shinichi, Ishimoto, Takuji, Kosugi, Tomoki, Tsuboi, Naotake, Ito, Yasuhiko, Maruyama, Shoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519470/
https://www.ncbi.nlm.nih.gov/pubmed/28674357
http://dx.doi.org/10.2169/internalmedicine.56.7908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519470/
https://www.ncbi.nlm.nih.gov/pubmed/28674357
http://dx.doi.org/10.2169/internalmedicine.56.7908

Ejemplares similares